Herpes Simplex Virus 2 gP IgG Control Serum BC1052G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Herpes Simplex Virus (HSV) 2 gP IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC1052G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, Herpes simplex Virus, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Herpes Simplex Virus 2 gP reactive IgG
species reactivity	Herpes Simplex Virus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Herpes Simplex Virus 2 gP IgG Control Serum BC1052G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Herpes simplex Virus 2 Glycoprotein G Antigen (BA1052RVS-G) Herpes simplex Virus 2 Antigen (BA1052VS) Herpes Simplex Virus 2 gP IgG Control Serum (BC1052G) Herpes Simples Virus 2 IgM Control Serum (BC1052M) Herpes simplex Virus 2 IgG ELISA Kit (ESR1052G) Herpes simplex Virus 2 IgM ELISA Kit (ESR1052M)

target relevance

human antibody anti-Herpes Simplex Virus (HSV)

Herpes Simplex Virus (HSV)

Description
Virus that causes oral herpes, genital herpes, and other mucocutaneous infections

Structure
Herpes simplex viruses (HSV) are enveloped, double-stranded DNA viruses belonging to the genus Simplexvirus within the family Herpesviridae. Two closely related species, Herpes simplex virus type 1 (HSV-1) and Herpes simplex virus type 2 (HSV-2), are responsible for the majority of human infections. The viral genome is enclosed within an icosahedral capsid surrounded by a protein tegument and a lipid envelope containing glycoproteins that mediate attachment and entry into host cells. Following primary infection, HSV establishes lifelong latency within sensory neurons, particularly in the trigeminal and sacral ganglia. Periodic reactivation of latent virus results in recurrent infections and viral shedding, often in the absence of symptoms. HSV infections are widespread globally and represent some of the most common viral infections of humans.

Diagnosis
The diagnosis of herpes simplex virus infection is performed through clinical evaluation and laboratory testing. Molecular methods such as polymerase chain reaction (PCR) are highly sensitive and specific and are considered the preferred diagnostic approach for detecting HSV DNA in lesion swabs, cerebrospinal fluid, and other clinical specimens. Viral culture may also be used, particularly for active lesions, although it is generally less sensitive than PCR. Direct fluorescent antibody testing and antigen detection assays may provide rapid identification in selected settings. Serological assays, including ELISA-based tests, can detect HSV-specific antibodies and help distinguish previous exposure to HSV-1 and HSV-2. Laboratory confirmation is particularly important in cases of neonatal herpes, encephalitis, and atypical presentations.

Symptoms
Herpes simplex virus infections produce a wide range of clinical manifestations depending on the site of infection and immune status of the host. Primary infection may be asymptomatic or may present with painful vesicular lesions involving the oral cavity, lips, genital region, skin, or eyes. HSV-1 most commonly causes oral herpes characterized by fever, gingivostomatitis, and recurrent cold sores, whereas HSV-2 is more frequently associated with genital herpes causing painful ulcers, itching, dysuria, and regional lymphadenopathy. Recurrent episodes are typically milder than primary infections due to partial immune control. In immunocompromised individuals and neonates, HSV can cause severe disseminated disease. Rare but serious complications include herpes encephalitis, keratitis leading to vision loss, meningitis, and neonatal herpes, which may be life-threatening if untreated.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application for the Herpes Simplex Virus 2 gP IgG Control Serum BC1052G?

The Herpes Simplex Virus 2 gP IgG Control Serum BC1052G is designed for use as an IgG control serum in ELISA assays, specifically for indirect and quantitative detection of HSV-2 antibodies.

How should the Herpes Simplex Virus 2 gP IgG Control Serum BC1052G be stored to maintain stability?

The control serum should be stored refrigerated at 2-8°C to ensure its stability and maintain performance.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC1052G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Herpes Simplex Virus 2 gP IgG Control Serum BC1052G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Herpes simplex Virus 1 and 2 IgG Lateral flow dipstick kit 5372

Borrelia burgdorferi IgG Control Serum BC121G

Herpes Simplex Virus 1+2 IgG Control Serum BC105G

Bordetella pertussis IgG Control Serum BC120G

Herpes Simplex Virus 1 gP IgG Control Serum BC1051G

Aspergillus fumigatus IgG Control Serum BC132G

Echovirus IgG Control Serum BC135G

Adenovirus IgG Control Serum BC128G

Echinococcus IgG Control Serum BC107G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G